605 related articles for article (PubMed ID: 29273397)
41. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
[TBL] [Abstract][Full Text] [Related]
42. Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.
Che Y; Hou L; Sun F; Zhang C; Liu X; Piao F; Zhang D; Li H; Wang Q
Cell Death Dis; 2018 Apr; 9(4):435. PubMed ID: 29568078
[TBL] [Abstract][Full Text] [Related]
43. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
44. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
45. Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Exerts Neurotoxicity in Models of Parkinson's Disease.
Wu Q; Yang X; Zhang L; Zhang Y; Feng L
Mol Neurobiol; 2017 Nov; 54(9):6970-6983. PubMed ID: 27785754
[TBL] [Abstract][Full Text] [Related]
46. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T; Zhang Z
Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
[TBL] [Abstract][Full Text] [Related]
47. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models.
Wang Q; Qian L; Chen SH; Chu CH; Wilson B; Oyarzabal E; Ali S; Robinson B; Rao D; Hong JS
Brain; 2015 May; 138(Pt 5):1247-62. PubMed ID: 25716193
[TBL] [Abstract][Full Text] [Related]
48. Minimally Toxic Dose of Lipopolysaccharide and α-Synuclein Oligomer Elicit Synergistic Dopaminergic Neurodegeneration: Role and Mechanism of Microglial NOX2 Activation.
Zhang W; Gao JH; Yan ZF; Huang XY; Guo P; Sun L; Liu Z; Hu Y; Zuo LJ; Yu SY; Cao CJ; Wang XM; Hong JS
Mol Neurobiol; 2018 Jan; 55(1):619-632. PubMed ID: 27975175
[TBL] [Abstract][Full Text] [Related]
49. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.
Chu Y; Morfini GA; Kordower JH
J Parkinsons Dis; 2016; 6(1):77-97. PubMed ID: 27003787
[TBL] [Abstract][Full Text] [Related]
50. Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures.
Tsutsumi R; Hori Y; Seki T; Kurauchi Y; Sato M; Oshima M; Hisatsune A; Katsuki H
Biochem Biophys Res Commun; 2019 Apr; 511(2):427-433. PubMed ID: 30803759
[TBL] [Abstract][Full Text] [Related]
51. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
52. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
53. Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation.
Han KA; Shin WH; Jung S; Seol W; Seo H; Ko C; Chung KC
Hum Mol Genet; 2017 Jan; 26(1):1-18. PubMed ID: 27798112
[TBL] [Abstract][Full Text] [Related]
54. Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration.
Song C; Kanthasamy A; Anantharam V; Sun F; Kanthasamy AG
Mol Pharmacol; 2010 Apr; 77(4):621-32. PubMed ID: 20097775
[TBL] [Abstract][Full Text] [Related]
55. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease.
Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR
Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity.
Francelle L; Outeiro TF; Rappold GA
Sci Rep; 2020 Apr; 10(1):6064. PubMed ID: 32269243
[TBL] [Abstract][Full Text] [Related]
57. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.
Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M
Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558
[TBL] [Abstract][Full Text] [Related]
58. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
[TBL] [Abstract][Full Text] [Related]
59. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
60. A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.
Choong CJ; Sasaki T; Hayakawa H; Yasuda T; Baba K; Hirata Y; Uesato S; Mochizuki H
Neurobiol Aging; 2016 Jan; 37():103-116. PubMed ID: 26545632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
